Efficacy of Intra-articular Injection of a Newly Developed Plasma Rich in Growth Factor (PRGF) Versus Hyaluronic Acid on Pain and Function of Patients with Knee Osteoarthritis: A Single-Blinded Randomized Clinical Trial
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Background and objectives: Knee osteoarthritis is the most common joint disease. We aimed to compare the efficacy and safety of intra-articular injection of a newly developed plasma rich in growth factor (PRGF) versus hyaluronic acid (HA) on pain and function of patients with knee osteoarthritis. Methods: In this single-blinded randomized clinical trial, patients with symptomatic osteoarthritis of knee were assigned to receive 2 intra-articular injections of our newly developed PRGF in 3 weeks or 3 weekly injections of HA. Our primary outcome was the mean change from baseline until 2 and 6 months post intervention in scores of visual analog scale, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and Lequesne index. We used analysis of variance for repeated-measures statistical test. Results: A total of 69 patients entered final analysis. The mean age of patients was 58.2 ± 7.41 years and 81.2% were women. In particular, total WOMAC index decreased from 42.9 ± 13.51 to 26.8 ± 13.45 and 24.4 ± 16.54 at 2 and 6 months in the newly developed PRGF group (within subjects P = .001), and from 38.8 ± 12.62 to 27.8 ± 11.01 and 27.4 ± 11.38 at 2 and 6 months in the HA group (within subjects P = .001), respectively (between subjects P = .631). There was no significant difference between PRGF and HA groups in patients’ satisfaction and minor complications of injection, whereas patients in HA group reported significantly lower injection-induced pain. Conclusions: In 6 months follow up, our newly developed PRGF and HA, both are effective options to decrease pain and improvement of function in patients with symptomatic mild to moderate knee osteoarthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“with greater satisfaction reported in these groups compared to hyaluronic acid and ozone therapy.”
From Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review (2025) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies by Angoorani et al . and Raeissadat et al . analyzed PRP, PRGF, hyaluronic acid, and ozone therapy, demonstrating that PRP and PRGF achieved significant pain reduction (VAS: -41.1--52.3%, P < 0.001)”
From Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and improvements in functionality (WOMAC: -36.2--55.3%, P < 0.001); [14,15]”
From Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“WOMAC: PRGF Δ-43.1%; VAS: Δ-41.0%.”
From Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“WOMAC: PRGF Δ-43.1%; VAS: Δ-41.0%.”
From Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review (2025) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hochberg, M. C., Altman, R. D., April, K. T., Benkhalti, M., Guyatt, G., McGowan, J., Towheed, T., Welch, V., Wells, G., & Tugwell, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21596 · Cited by 3,068
Dohan Ehrenfest, D. M., Rasmusson, L., & Albrektsson, T. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.11.009 · Cited by 2,008
Moreland, L. W. (2003) · Arthritis Research · doi:10.1186/ar623 · Cited by 777
Patel, S., Dhillon, M. S., Aggarwal, S., Marwaha, N., & Jain, A. (2013) · The American Journal of Sports Medicine · doi:10.1177/0363546512471299 · Cited by 762
Treatment of Osteoarthritis of the Knee: Evidence-Based Guideline, 2nd Edition
Jevsevar, D. S. (2013) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/00124635-201309020-00008 · Cited by 634
Viscosupplementation: a new concept in the treatment of osteoarthritis.
Balazs, E. A., & Denlinger, J. L. (1993) · PubMed · Cited by 595
The potential impact of the preparation rich in growth factors (PRGF) in different medical fields
Anitua, E., Sánchez, M., Orive, G., & Andía, I. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.06.037 · Cited by 526
Anitua, E., Andí, I., Sanchez, M., Azofra, J., del Mar Zalduendo, M., de la Fuente, M., Nurden, P., & Nurden, A. T. (2005) · Journal of Orthopaedic Research · doi:10.1016/j.orthres.2004.08.015 · Cited by 505
Dai, W.-L., Zhou, A.-G., Zhang, H., & Zhang, J. (2017) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2016.09.024 · Cited by 444
Schmidt, M. B., Chen, E. H., & Lynch, S. E. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.10.011 · Cited by 415
Platelet-Rich Plasma Releasate Inhibits Inflammatory Processes in Osteoarthritic Chondrocytes
van Buul, G. M., Koevoet, W. L. M., Kops, N., Bos, P. K., Verhaar, J. A. N., Weinans, H., Bernsen, M. R., & van Osch, G. J. V. M. (2011) · The American Journal of Sports Medicine · doi:10.1177/0363546511419278 · Cited by 407
Filardo, G., Kon, E., Pereira Ruiz, M. T., Vaccaro, F., Guitaldi, R., Di Martino, A., Cenacchi, A., Fornasari, P. M., & Marcacci, M. (2012) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-011-1837-x · Cited by 405
Sánchez, M., Fiz, N., Azofra, J., Usabiaga, J., Aduriz Recalde, E., Garcia Gutierrez, A., Albillos, J., Gárate, R., Aguirre, J. J., Padilla, S., et al. (2012) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2012.05.011 · Cited by 403
Görmeli, G., Görmeli, C. A., Ataoglu, B., Çolak, C., Aslantürk, O., & Ertem, K. (2017) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-015-3705-6 · Cited by 401
Filardo, G., Di Matteo, B., Di Martino, A., Merli, M. L., Cenacchi, A., Fornasari, P., Marcacci, M., & Kon, E. (2015) · The American Journal of Sports Medicine · doi:10.1177/0363546515582027 · Cited by 363
Sánchez, M., Anitua, E., Azofra, J., Aguirre, J. J., & Andı́a, I. (2008) · PubMed · Cited by 341
Adams, M. E., Atkinson, M. H., Lussier, A. J., Schulz, J. I., Siminovitch, K. A., Wade, J. P., & Zummer, M. (1995) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(05)80013-5 · Cited by 341
Raeissadat, S. A., Rayegani, S. M., Hassanabadi, H., Fathi, M., Ghorbani, E., Babaee, M., & Azma, K. (2015) · Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders · doi:10.4137/cmamd.s17894 · Cited by 331
Self-citationDuymus, T. M., Mutlu, S., Dernek, B., Komur, B., Aydogmus, S., & Kesiktas, F. N. (2017) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-016-4110-5 · Cited by 297
Platelet-rich plasma therapy - future or trend?
Dhillon, R. S., Schwarz, E. M., & Maloney, M. D. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3914 · Cited by 287
Ulrich-Vinther, M., Maloney, M. D., Schwarz, E. M., Rosier, R., & OʼKeefe, R. J. (2003) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/00124635-200311000-00006 · Cited by 278
Filardo, G., Kon, E., Roffi, A., Di Matteo, B., Merli, M. L., & Marcacci, M. (2015) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-013-2743-1 · Cited by 270
Vaquerizo, V., Plasencia, M. Á., Arribas, I., Seijas, R., Padilla, S., Orive, G., & Anitua, E. (2013) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2013.07.264 · Cited by 259
Wang-Saegusa, A., Cugat, R., Ares, O., Seijas, R., Cuscó, X., & Garcia-Balletbó, M. (2011) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-010-1167-3 · Cited by 242
Murphy, L., & Helmick, C. G. (2012) · Orthopaedic Nursing · doi:10.1097/nor.0b013e31824fcd42 · Cited by 177
Pujol, J. ‐., Chadjichristos, C. E., Legendre, F., Baugé, C., Beauchef, G., Andriamanalijaona, R., Galéra, P., & Boumédiene, K. (2008) · Connective Tissue Research · doi:10.1080/03008200802148355 · Cited by 167
Montañez‐Heredia, E., Irízar, S., Huertas, P. E., Otero, E., del Valle, M., Prat, I., Díaz-Gallardo, M., Perán, M., Marchal, J. A., & Hernandez-Lamas, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071064 · Cited by 156
Platelet Rich Plasma Treatment for Chronic Achilles Tendinosis
Monto, R. R. (2012) · Foot & Ankle International · doi:10.3113/fai.2012.0379 · Cited by 139
Frazer, A., Bunning, R. A. D., Thavarajah, M., Seid, J. M., & Russell, R. G. G. (1994) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(05)80075-5 · Cited by 136
(2014) · Orthopedic Review · doi:10.4081/or.2014.5405 · Cited by 112
Self-citationThe role of chondrocyte–matrix interactions in maintaining and repairing articular cartilage
Martin, J. A., & Buckwalter, J. A. (2000) · Biorheology: The Official Journal of the International Society of Biorheology · doi:10.1177/0006355x2000037001002009 · Cited by 108
O’Keefe, R. J., Crabb, I. D., Puzas, J. E., & Rosier, R. N. (1994) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100120302 · Cited by 92
Nadrian, H., Moghimi, N., Nadrian, E., Moradzadeh, R., Bahmanpour, K., Iranpour, A., & Bellamy, N. (2012) · Clinical Rheumatology · doi:10.1007/s10067-012-1983-7 · Cited by 87
Anitua, E., Sánchez, M., Aguirre, J. J., do Prado, R. C. P., Padilla, S., & Orive, G. (2014) · Arthroscopy The Journal of Arthroscopic and Related Surgery · doi:10.1016/j.arthro.2014.05.021 · Cited by 83
Autologous Platelet-Rich Plasma: A Revolution in Soft Tissue Sports Injury Management?
Mei-Dan, O., Lippi, G., Sánchez, M., Andia, I., & Maffulli, N. (2010) · The Physician and Sportsmedicine · doi:10.3810/psm.2010.12.1835 · Cited by 83
Raeissadat, S. A., Rayegani, S. M., Babaee, M., & Ghorbani, E. (2013) · Pain Research and Treatment · doi:10.1155/2013/165967 · Cited by 70
Self-citationLana, J. F., Santana, M. H. A., Belangero, W. D., & Luzo, Â. C. M. (2013) · Lecture notes in bioengineering · doi:10.1007/978-3-642-40117-6 · Cited by 68
Raeissadat, S. A., Sedighipour, L., Rayegani, S. M., Bahrami, M. H., Bayat, M., & Rahimi, R. (2014) · Pain Research and Treatment · doi:10.1155/2014/191525 · Cited by 66
Self-citationPrevalence of osteoarthritis in rural areas of I ran: a WHO ‐ ILAR COPCORD study
Tehrani‐Banihashemi, A., Davatchi, F., Jamshidi, A., Faezi, T., Paragomi, P., & Barghamdi, M. (2014) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12312 · Cited by 59
Plasma rico en plaquetas: ¿un nuevo tratamiento para el reumatólogo?
Mata, J. D. L. (2013) · Reumatología Clínica · doi:10.1016/j.reuma.2012.05.011 · Cited by 55
Autologous Platelet Gel and Platelet-Poor Plasma Reduce Pain With Total Shoulder Arthroplasty
Zavadil, D. P., Satterlee, C. C., Costigan, J. M., Holt, D. W., & Shostrom, V. (2007) · Journal of ExtraCorporeal Technology · doi:10.1051/ject/200739177 · Cited by 48
An Overview of Platelet Products (PRP, PRGF, PRF, etc.) in the Iranian Studies
Raeissadat, S. A., Babaee, M., Rayegani, S. M., Hashemi, Z., Hamidieh, A. A., Mojgani, P., & Vanda, H. F. (2017) · Future Science OA · doi:10.4155/fsoa-2017-0045 · Cited by 47
Self-citationA biological therapy to osteoarthritis treatment using platelet-rich plasma
Anitua, E., Sánchez, M., Orive, G., & Padilla, S. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.801450 · Cited by 44
Platelet Rich Plasma. A New Treatment Tool for the Rheumatologist?
Mata, J. D. L. (2012) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2012.05.006 · Cited by 43
Managing joint pain in osteoarthritis: safety and efficacy of hylan G-F 20
Baker Jr., C., Conduah, Baker, I. I. I., & Binns (2009) · Journal of Pain Research · doi:10.2147/jpr.s4732 · Cited by 42
Autologous platelet gel and platelet-poor plasma reduce pain with total shoulder arthroplasty.
Zavadil, D. P., Satterlee, C. C., Costigan, J. M., et al. (2007) · PubMed · doi:10.1051/ject/200739177/pdf · Cited by 40
Research works printed but not linked: 1
- Anitua E Sánchez M Orive G A biological therapy to osteoarthritis treatment using platelet-rich plasma. Expert Opin. 2013; 13: 1161– 1172. 23834251 · DOI · Paper page
Cited by
Belk, J. W., Kraeutler, M. J., Houck, D. A., Goodrich, J. A., Dragoo, J. L., & McCarty, E. C. (2021) · The American Journal of Sports Medicine · doi:10.1177/0363546520909397 · Cited by 432
“Multiple studies have attributed the improved outcomes with PRP to its autologous makeup and high concentration of growth factors,(1,17,29,30,39) although many studies demonstrate HA to be just as effective.(13,18,33,43) Therefore, we hypothesized that there would be no difference in clinical outcomes between patients…”
BackgroundFilardo, G., Previtali, D., Napoli, F., Candrian, C., Zaffagnini, S., & Grassi, A. (2021) · CARTILAGE · doi:10.1177/1947603520931170 · Cited by 294
Raeissadat, S. A., Ghazi Hosseini, P., Bahrami, M. H., Salman Roghani, R., Fathi, M., Gharooee Ahangar, A., & Darvish, M. (2021) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-04017-x · Cited by 181
“has shown that HA and PRGF had similar effects 2 and 6 months after with no meaningful difference between the groups [12].”
BackgroundSelf-citationHan, Y., Huang, H., Pan, J., Lin, J., Zeng, L., Liang, G., Yang, W., & Liu, J. (2019) · Pain Medicine · doi:10.1093/pm/pnz011 · Cited by 155
“WOMAC stiffness scores were reported by two [2,32], three [2,32,39], five [2,21,32,37,38], and four studies [2,21,32,36] at one, three, six, and 12 months, respectively.”
BackgroundMethodInfluentialChavda, S., Rabbani, S. A., & Wadhwa, T. (2022) · Cureus · doi:10.7759/cureus.24503 · Cited by 148
“The different formulations of I-HA [37] were studied for safety and efficacy of I-HA in combination or in comparison with corticosteroids [37,38] collagen [39] bone marrow-derived mononuclear cells [40] umbilical cord-derived mesenchymal stromal cells [41] bone marrow mesenchymal stem cells [42] ozone therapy [43] pol…”
BackgroundResult
Metadata
- Authors
- Raeissadat, S. A., Rayegani, S. M., Ahangar, A. G., Abadi, P. H., Mojgani, P., & Ahangar, O. G.
- Affiliations
- Shahid Beheshti University (IR)
- University of Birmingham (GB)
- Rehabilitation and Medical Education Department, Iran Helal institute of Applied Sciences and Technology, affiliated to the Red Crescent Society of Iran, Tehran, Iran
- Corresponding author
- Ahangar, Azadeh Gharooee
- Venue
- Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders
- Publisher
- SAGE Publications
- Published
- 2017-01
- Volume
- 10
- Pages
- 1179544117733452-1179544117733452
- ISSN
- 1178-1149 (ISSN-L)
- 1179-5441
- PMC
- PMC5638152
- OpenAlex
- W2761873219
- Cited by
- 70
- References
- 45
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 9 · 2023: 5 · 2022: 5 · 2021: 10 · 2020: 17 · 2019: 7 · 2018: 6
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Clinical Medicine Insights Arthritis and Musculoskeletal Disorders (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Tendon Structure and Treatment
- Keywords
- knee osteoarthritis, plasma rich in growth factors, hyaluronic acid, intra-articular injection, pain, functional outcome, WOMAC index, Lequesne index, injection complications, patient satisfaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.